[EMNR (10) B Roster]

The EMNR Small Business SEP [EMNR (10)] considers SBIR/STTR standing SEP reviews applications in areas concerned with the endocrine, metabolic and nutritional basis of  diabetes and obesity. Specifically neuroendocrine basis of energy expenditure and weight management, pathogenesis of obesity and diabetes and their management utilizing new and improved therapeutic strategies, bioengineering approaches in monitoring metabolic and nutritional biomarkers. In general EMNR E10 covers science range of IPOD, INMP, CADO and CIDO study sections.

• Energy expenditure, thermogenesis, physical activity, and exercise in the context of the pathogenesis or treatment of obesity and diabetes. Nutrient and dietary intervention in the treatment of these metabolic and endocrine disorders.
• Adipocyte functions, including: nutrient storage and release, and communication with other organs and tissues.
• Neuroendocrinology and pharmacological interventions in metabolic disorders.
• Biosensor (e.g., glucose sensors etc.) to effect continuous glucose monitoring for effective treatment of diabetes utilizing micro and nanosensor technologies. Drug and nutrient delivery across cell and tissue systems.
• Differentiation, development, growth, and function of pancreatic islets. Beta cell viability and methods at optimization for use in islet transplantation and cell based therapies

Small Business SEP panels of IRGs with most closely related areas of similar science listed in rank order are:

Digestive, Kidney and Urological Systems IRG
Bioengineering Sciences and Technologies IRG 
Risk, Prevention, and Health Behavior IRG
Musculoskeletal, Oral and Skin Sciences IRG
Integrative, Functional, and Cognitive Neuroscience IRG